Brain mitochondria are relatively resistant to calciuminduced mitochondrial permeability transition (MPT), with heterogenic response to the insult. The cause for this heterogeneity is not clear, so we studied the distribution of a key regulator of the MPT, cyclophilin D (cypD), within the rat brain by using immunohistology and Western blotting. Motor and parietal cortex, hippocampus, striatum, substantia nigra, ventral tegmental area, septum, and mammillary nucleus displayed a strong immunoreactivity to cypD within specific subpopulation of neurons. The staining was punctate and intense, particularly in perinuclear regions of cells. Apart from neurons, a subpopulation of astrocytes and NG2-positive cells showed higher cypD immunoreactivity. Double staining of cypD with cytochrome oxidase confirmed the mitochondrial specificity of cypD immunoreactivity. The neurons with high levels of cypD also expressed glutamate decarboxylase (GAD) and the calcium binding protein parvalbumin or calbinding D-28k, identifying these cells as interneurons. Western blots confirmed our immunohistochemical findings, showing significantly higher levels of cypD in crude mitochondria of substantia nigra compared with cortex or striatum. Furthermore, nonsynaptic mitochondria representing mainly mitochondria from cell bodies of neurons and glia have about 16% higher levels of cypD compared with synaptic mitochondria that are localized in presynaptic buttons. These data suggest that the underlying factor of heterogenic response of isolated brain mitochondria to MPT-inducing insults can be the different expression levels of cypD, with mitochondria originated from interneurons as the most sensitive. V V C 2008 Wiley-Liss, Inc.
Mitochondria have a fundamental role in regulating both apoptotic and necrotic cell death predominantly through the formation of the permeability transition pore (PTP). The opening of this pore is regulated by the mitochondrial protein cyclophilin D (cypD; Halestrap and Davidson, 1990; Bernardi et al., 1992) . Cyclophilins represent a subgroup of a large family of enzymes called peptidyl cis-trans isomerases (PPI) that bind the immunosuppressant cyclosporine A (CsA) and catalyze the cistrans isomerization of peptide bonds preceding proline residues (Schmid, 1993 (Schmid, , 1995 . A physiological role for PPIases as catalysts of cellular protein folding reactions and a possible relation to molecular chaperones have been suggested (for review see Gothel and Marahiel, 1999) .
Cyclophilin D is a mitochondrially targeted cyclophilin, which has been implicated in accelerating the folding of newly imported protein into mitochondria (Matouschek et al., 1995; Rospert et al., 1996) and in regulation of a mitochondrial permeability transition (MPT) pore assembly. It is commonly accepted that activation of MPT is a result of the interaction and conformational changes of several mitochondrial proteins (for review see Crompton, 2003) . This process is catalyzed by cypD that is localized in the matrix. Initial evidence supporting the idea that cypD plays a direct role in the MPT emerged from an examination of the ability of CsA to inhibit PPIase activity, which correlated with inhibition of the MPT (Griffiths and Halestrap, 1991; Connern and Halestrap, 1992) . Finally, purification of CsA binding proteins from total mitochondrial extracts by CsA affinity chromatography demonstrated that only cypD could be specifically eluted (Nicolli et al., 1996) . The sensitivity of mitochondria to calcium-induced MPT is dependent on the expression levels of cypD (Brustovetsky et al., 2003; Eliseev et al., 2007) . Thus, cypD is likely a key regulator of MPT activity. Recent studies using cypD null mice revealed the essential role of this protein and the MPT in necrotic cell death caused by calcium overload and oxidative stress (Li et al., 2004; Basso et al., 2005) .
The MPT opening probability is modulated by several factors and drugs (Gunter and Pfeiffer, 1990) , most importantly, calcium. Furthermore, the mitochondrial response to calcium-induced MPT has tissue-specific characteristics (Kristal and Dubinsky, 1997; Dubinsky et al., 1999; Brustovetsky and Dubinsky, 2000; Kristal et al., 2000 Kristal et al., , 2001 . Unlike mitochondria of liver or heart origin, brain mitochondria are relatively resistant to calcium-induced swelling (Andreyev and Fiskum, 1999; Berman et al., 2000; Eliseev et al., 2007) . When swelling of brain mitochondria was examined, a clearcut heterogeneity in response to calcium was revealed (Kristián et al., 2000 (Kristián et al., , 2001 (Kristián et al., , 2002 . Although a small subpopulation of brain mitochondria showed typical characteristics of swelling, and some mitochondria were without significant morphological alterations, the majority of mitochondria displayed shrunken matrices, with expansion of the intermembrane space (Kristián et al., 2002 (Kristián et al., , 2007 . The mechanisms underlying this heterogenic response are elusive, but the response could result from differential cypD expression levels in neurons and glia or within different brain regions.
We hypothesize that the cypD expression is heterogeneous within different brain regions or cells types. Therefore, in the present study, we examined cypD distribution in the adult rodent brain. Immunohistochemistry and immunoblotting techniques were utilized to detect this protein in different cell types of the brain and in isolated mitochondria from specific brain regions.
MATERIALS AND METHODS Animals and Fixation
Five naïve adult (300 g) male Fisher 344 rats were deeply anesthetized with ketamine and transcardially perfused with 4% paraformaldehyde. Brains were removed from the skull and transferred into 30% sucrose. Once the brains had sunk to the bottom of the container, they were cut (30 lm) on a freezing sliding microtome and kept in cryoprotectant (2208C) until further processing was initiated (Watson et al., 1986) .
Nickel-Diaminobenzidine Tetrahydrochloride Visualization of cypD
Sections were rinsed multiple times in 0.05 M potassium phosphate-buffered saline (KPBS) buffer before and after exposure to a 1% solution of sodium borohydride for 20 min; primary antibody for 48 hr (MitoSciences; anticyclophilin D; 1:80,000); goat anti-mouse secondary antibody (1:600) for 1 hr; and avidin-biotin complex (1:222) solution for 1 hr. Tissue was rinsed before and after a 12-min incubation in nickeldiaminobenzidine tetrahydrochloride (NiDAB) solution with 0.175 M sodium acetate buffer.
Double-Labeling Immunofluorescence
Sections were processed as described above with the addition of a blocking step against endogenous avidin-biotin activity immediately prior to incubation in the primary antibody (anti-cypD; 1:50,000) for 48 hr. Tissue was then rinsed with KPBS before and after incubation in goat anti-mouse secondary antibody (1:5,000, 60 min), avidin-biotin complex solution (1:444, 30 min), biotinylated tyramide (1:200, 20 min), and streptofluor 594 (1:200, 90 min). Tissue was incubated in a second primary antibody for 48 hr, rinsed in KPBS, and exposed to appropriate AlexaFluor secondary antibody for 1 hr. Second primary antibodies included the following: Chemicon (Temecula, CA) mouse anti-NeuN, 1:50,000; Chemicon rabbit anti-GAD67/65, 1:30,000; Sigma (St. Louis, MO) rabbit antiparvalbumin, 1:30,000; Swant (Belinzona, Switzerland) mouse anticalbindin-D28k,1:60,000; Molecular Probes (Eugene, OR) mouse anti-COX, 1:12,000; Dako (Carpinteria, CA) rabbit anti-GFAP, 1:25,000; Chemicon rabbit anti-NG2, 1:1,000; Wako (Osaka, Japan) rabbit anti-Iba-1, 1:9,000; and Abcam (Cambridge, MA) mouse anti-CNPase, 1:20,000. When two primaries from the same host species were used, tissue was blocked with 0.1% normal mouse serum and F(ab) 2 fragments (1:8,000) prior to incubation in the second primary antibody. Three to five sections were examined for each brain region with positive immunoreactivity. The sections were examined with Nikon Eclipse E800 microscope, using brightfield optics for NiDAB-stained sections and with an E600W microscope equipped with a confocal cell imaging system CARV with appropriate filters for the fluorochrometreated sections. As a control, the staining procedure was repeated with omission of the primary antibody, resulting in the absence of any specific labeling. For double-labeling controls, we treated tissue with one of the two primaries, followed by sequential incubation in each appropriate secondary. This procedure confirmed the specificity of each antibody used in this study.
Western Blotting
Immunoblot analysis was performed according to a method described previously . Aliquots of isolated nonsynaptic and synaptic mitochondria (5 lg protein) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). To compare the relative levels of cypD between different brain regions, crude mitochondrial samples were purified from homogenates of dissected brain tissues. Nonsynaptic, synaptic, and crude mitochondrial samples were mixed with lysis buffer (0.5% Nonidet P-40, 1% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 7.4) and sonicated for 30 sec (Sonicator 3000; Misonix Inc., Farmingdale, NY). Five micrograms of protein was used for loading each lane of the SDS-PAGE gels. After transfer to polyvinylidene fluoride (PVDF) membranes (Invitrogen, La Jolla, CA), the membranes were washed with phosphate-buffered saline with 0.05% Tween 20 (PBST) and fixed in a 0.1% glutaraldehyde in PBST for 10 min. The membranes were washed and incubated in 5% nonfat milk in PBST for 2 hr, then incubated overnight at 48C with monoclonal antibody for cyclophilin D (1:10,000) and for porin (VDAC; 1:10,000; Mitosciences, LLC). This was followed by washing the membranes in PBST and incubation for 2 hr in horseradish peroxidase (HRP)-conjugated anti-mouse IgG (1:10,000; Cell Signaling Technology, A-E: Hippocampus. The intensity of staining within the cellular layers is highest in CA3 (E), followed by subiculum (B), CA1, and dentate gyrus (D). Furthermore, the immunoreactivity is particularly high above and below the hippocampal fissure and within the cellular and basal dendritic layers of CA3. There are scattered cells with intense staining throughout all hippocampal regions. B-E are enlarged images of boxed areas. F-H: Caudate putamen and overlaying cortex. Intense immunoreactivity within caudate putamen, with scattered strongly stained neurons (arrowheads; H). Strongly stained neurons are localized particularly in cortical layers II/IV and VI (G). Neurons with high cypD immunoreactivity were also localized in layer I of piriform cortex. Furthermore, nonneuronal cells in deeper layers within this region were also strongly stained (I; arrowheads). Substantia nigra (SNr), ventral tegmental area (VTA), mammilary nucleus (MN; K-M), and septum (N) contained neurons with intense staining. O and P demonstrate individual neurons within the CA1 (O) and the CA3 (P) sector of the hippocampus with high immunoreactivity. Arrowheads indicate nonneuronal cells with high levels of cypD staining. Scale bars 5 100 lm.
Beverly, MA) antibody. Immunoreactive bands were visualized with the enhanced chemiluminescent detection reagents (Amersham Biosciences, Arlington Heights, IL). Optical densities of individual bands were quantified after subtraction of background levels of film exposure using the GelExpert software (Nucleotech, San Carlos, CA).
Isolation of Brain Mitochondria
Nonsynaptic brain mitochondria were isolated according to Sims (1990) , with slight modifications (see Kristián et al., 2002) . Briefly, brains were rapidly removed and homogenized in ice-cold isolation medium (225 mM mannitol, 75 mM sucrose, 1 mM EGTA, 5 mM Hepes-Tris, pH 7.4, at 48C). The brain homogenate was centrifuged at 1,300g for 3 min. After removal of the supernatant, the pellet was resuspended in the isolation medium and centrifuged again at 1,300g for 3 min. The supernatant was then combined with the supernatant from the previous spin and centrifuged at 17,000g for 10 min. The resulting pellet was resuspended in 15% Percoll and layered on top of a discontinuous Percoll gradient (40%, 24%). After centrifugation of the gradient at 32,000g for 8 min, the mitochondria sedimented at the lower interface between 40% and 24% Percoll. The synaptosomes accumulated below the interface of 24% and 15% Percoll. The nonsynaptic mitochondria were collected and diluted in isolation medium (1:5 vol/vol). After centrifugation at 17,000g for 10 min, the pellet was resuspended in isolation medium containing 10 mg/ml of defatted bovine serum albumin (BSA) and centrifuged at 7,000g for 10 min. The synaptosomes were collected and diluted with isolation medium (1:1 vol/vol), and the mitochondria were released from synaptosomes using a nitrogen cavitation technique . The suspension was layered onto 24% Percoll and then centrifuged at 32,000g for 8 min. The synaptic mitochondria that sedimented at the bottom of the tube were collected and diluted in isolation medium (1:5 vol/vol). After centrifugation, the pellet was resuspended in bovine serum albumin (BSA)-containing medium and centrifuged at 7,000g for 10 min. The final mitochondrial pellet was resuspended in 0.5 ml lysis buffer.
The crude mitochondrial samples from dissected brain regions of cortex, striatum, and substantria nigra were prepared by homogenization of brain tissue, followed by lowspeed centrifugation at 1,300g for 3 min. The supernatant was then centrifuged at 17,000g for 10 min. The obtained pellet was resuspended in isolation medium and centrifuged again at 7,000g for 10 min. The final crude mitochondrial pellet was diluted in lysis buffer.
Data Analysis
Statistical differences among different groups were determined by using one-way ANOVA followed by Scheffe's Ftest. A paired t-test was used to assess the difference in cypD levels between synaptic and nonsynaptic mitochondrial samples. Differences with P < 0.05 were considered to be statistically significant. All errors are given as SEM.
RESULTS
Because the distribution of cypD throughout the brain is unknown, we initially performed an entire rostral-to-caudal qualitative screen of every twelfth section for the immunohistochemical detection of cypD-positive cells. For the purposes of this study, we focused on only those areas showing the highest number of cells with specific cypD immunoreactivity indicated by a black insoluble deposit at the site of the antigen. The immunoreactivity observed in neuronal cells appeared in two primary patterns. In the first, a zone of punctate staining was observed uniformly around the nucleus (Fig. 1E) . In the second, a more intense punctate somatic staining was observed diffusely throughout most of the cytoplasm and extended into one or more dendritic processes (Fig. 1O) . Neurons exhibiting both patterns of staining were estimated from each region and included in the relative number of positive cells per 90,000 lm 2 reported in Table I . At low magnification, cypD immunostaining was localized predominantly in neurons within the hippocampus, striatum, cortex, septum, substantia nigra (SNr), ventral tegmental area (VTA), and lateral mammillary nucleus (LMN; see Table I ). Within the hippocampus, clear immunoreactivity was observed in the pyramidal cell layer, with strongly stained neurons scattered throughout both cellular and molecular layers (Fig. 1A-E) . Generally, staining in stratum moleculare of all hippocampal subregions was consistently intense (Fig. 1D) . The basal dendritic (stratum oriens) layers appeared more immunoreactive than the proximal apical dendritic layer. The immunoreactivity observed within stratum moleculare was moderate compared with cellular layers. At higher magnification, individual neurons with densely punctate labeling in their cytoplasm, dendrites, and glialike processes (Fig. 1O,P) were interspersed with the neurons exhibiting a granular staining pattern only in the neuropil and somata. Staining was also evident within nonneuronal cell types in these regions.
Other brain regions displaying neurons with strong cypD immunoreactivity were cortex, striatum, septum, SNr, VTA, and LMN (Fig. 1F-N) . Cortical neuron staining was heterogeneous, localized primarily in perinuclear regions and in the proximal segment of axons. Neurons with stronger staining were scattered within laminae II, III, IV, and VI (Fig. 1G) , mainly in the frontal cortex. Moderately stained neurons were also observed in the parietal cortex. Strongly labeled neurons were localized in the posterior piriform cortex (Fig. 1I) . These neurons show intense punctate staining in perinuclear regions. In this area of the cortex, there is also a spotted immunostaining of small cells with a nonneuronal morphology (Fig. 1I) . Caudate putamen displayed a scattered immunoreactivity with strongly stained medium-sized spiny cells (Fig. 1H) . Similarly, VTA, SNr, and LMN neurons with spiny somas and dendrites were clearly cypD immunoreactive (Fig. 1K-M) . Strongly reactive neurons were localized in septal regions, with mostly perinuclear staining (Fig. 1N) . Little or no staining was observed in several brain regions, including the cerebellum, nucleus accumbens, corpus callosum, cortical layer I, and geniculate nucleus.
Because cypD is a mitochondrial protein, we used cytochrome oxidase (COX) subunit I antibody to confirm mitochondrial localization of the cypD staining. Figure 2A -C demonstrates colocalization of COX and cypD immunoreactivity. To determine which nonneuronal cell types expressed cypD immunoreactivity, tissue was colabeled with antibodies against glial markers for astrocytes (GFAP and S100b), microglia (Iba1), oligodendrocytes (CNPase), and synantocytes (cells expressing NG2 chondroitin sulfate proteoglycan; for review see Butt et al., 2005) . There was no clear overlap between cypD immunoreactivity and microglial or oligodendrocyte markers. However, double labeling with GFAP and S100b staining revealed a subset of mitochondria in astrocytes expressing high levels of cypD. A clear cypD signal was present in the thick proximal processes of the GFAP-or S100b-labeled astrocytes ( Fig.  2D-I) . Similarly, mitochondria in a subpopulation of NG2 cells within piriform cortex and hippocampal regions showed strong immunoreactivity to cypD, particularly in perinuclear regions (Fig. 2J-L) .
To confirm quantitative differences in cypD levels between various brain regions and cell types, we isolated mitochondria from regions showing strong immunoreactivity, analyzed cypD levels by Western immunoblots, and quantified the individual cypD band intensities. Typical examples of immunoreactivity to cypD of mitochondrial samples obtained from cortex, striatum, and substantia nigra are shown in Figure 3A . The immunoreactivity to VDAC (a mitochondrial outer membrane protein) was used as a loading control. The content of cypD was 40-50% higher in the SNr mitochondrial fraction compared with the cortical sample and 33% higher compared with mitochondria from the striatum (Fig.  3B) . In nonsynaptic mitochondria (representing mitochondria from glia and neuronal cell bodies), the cypD level was 16% higher than in the synaptic fraction (representing mitochondria from neuron terminals).
The morphology and distribution of neurons with high cypD immunoreactivity in most brain regions resemble GABAergic interneurons. These GABAergic interneurons are characterized by knotted dendrites and the expression of glutamic acid decarboxylase (GAD) and high levels of the calcium binding proteins parvalbumin or calbindin. We therefore examined whether neurons with strong cypD immunoreactivity also showed positive staining with markers of GABAergic cells. As Figure 4 shows, there is a clear overlap of GAD and cypD immunostaining in the septal area (Fig. 3A-C) , in caudate putamen (Fig. 4D-F) , in cells of hippocampal regions (Fig. 4G-I) , and throughout the substantia nigra (Fig. 4J-L) . Similarly, immunoreactivity to parvalbumin was colocalized with cypD-positive staining in a subset of hippocampal neurons (Fig. 5A-C) , in neurons of the mammillary nucleus (Fig. 5D-F ) and piriform cortex (Fig. 5G-I ). CypD-positive neurons in cortex also expressed high levels of calbindin-D28k (Fig. 5K-M) . Taken together, these data suggest that GABAergic interneurons are in fact one of the richest sources of mitochondrial cypD in the adult rodent brain.
DISCUSSION
The results from this study demonstrate that different levels of the mitochondrial matrix protein cypD exist within various brain regions and between different cell types. CypD immunostaining in individual cells was punctate and localized generally in perinuclear regions and proximal dendrites. Interestingly, the cypD distribution within the hippocampus was similar to the distribution of cytochrome oxidase (COX) and cytochrome c (cyt c; Kageyama, 1982; Chandrasekaran et al., 2006 ; see also Naga and Geddes, 2007) . However, although the cypD immunoreactivity within the pyramidal cell layer was homogenous, cells with particularly strong positive staining were scattered throughout the hippocampus. The distribution pattern of strongly labeled neurons suggested that high levels of cypD were expressed in a subpopulation of GABAergic interneurons. Double staining with cypD and markers of interneurons (GAD, PV, or calbindin-D28k) revealed that the neurons with high Fig. 3 . Relative distribution of cypD in crude mitochondrial samples from different brain regions and in nonsynaptic and synaptic mitochondria. Cyclophilin D immunoreactivity was normalized to the VDAC signal. The normalized immunoreactivity is significantly higher in substantia nigra (SNr) compared with cortex (Cor) and striatum (Str; P < 0.05, n 5 4; A). Nonsynaptic mitochondria (NSM) demonstrated significantly higher levels of cypD compared with synaptic mitochondria (SNM; *P < 0.05, n 5 6; B).
cypD immunoreactivity express GAD and mostly PV. In addition to neurons, nonneuronal cells demonstrated positive immunoreactivity to cypD (see also Naga and Geddes, 2007) . These cells represent a subset of astrocytes and NG2 cells. The presence of the cypD signal in the thick proximal processes of astrocytes was similar to the distribution of cyt c in astrocytes (Gulyas et al., 2006) .
High immunoreactivity within individual cells can be a result of either selectively higher expression of cypD or simply a greater number of mitochondria in these cells. Fluorescence staining revealed that the stained organelles were brighter in positive cells rather than occurring in greater numbers compared with cells with low immunoreactivity, suggesting higher levels of the cypD in individual mitochondria.
Cells with intense cypD staining in Str, Sep, SNr, VTA, and cortex also coexpressed GAD and calciumbinding proteins, characteristic of interneurons (for review see Celio, 1990) . Unlike the case in the hippocampus, most of the cypD positively stained cortical neurons expressed high levels of calbindin-D28k. In the Fig. 4 . CypD is highly expressed in GABA-ergic interneurons. Double staining with anti-cypD (red) and anti-GAD (green) of septum (A-C), caudate putamen (CP; D-F), CA3 region of the hippocampus (G-I), and substantia nigra (SNr; J-L). The merged images demonstrate that neurons with high cypD immunoreactivity express glutamate decarboxylase (GAD). Scale bar 5 50 lm.
[Color figure can be viewed in the online issue, which is available at www.interscience. wiley.com.] substantia nigra, positive cypD immunoreactivity was present in interneurons and also was enriched in cells within the pars reticulara, suggesting increased cypD levels in dopaminergic neurons.
These data suggest that, in all brain regions with strong cypD immunostaining, high levels of cypD are expressed in GABAergic interneurons. In general, interneurons, particularly those expressing PV, are the most active cells showing high discharge rates (Csicsvari et al., 1999; Pawelzik et al., 2002; Klausberger et al., 2005) . The high energy demand of these cells is reflected in higher levels of mitochondrial respiratory enzymes (McCasland and Hibbard, 1997; Attwell and Laughlin, 2001) , requiring faster turnover of mitochondrial proteins. Therefore, the higher levels of cypD could be the results of a need for faster refolding of newly imported proteins (Schatz, 1996) .
The quantitative comparison of the cypD levels between nonsynaptic mitochondria, enriched with those from glia and neuronal cell bodies, and synaptic mito- chondria, enriched with those from nerve terminals, indicates that the nonsynaptic fraction has higher levels of cypD. This finding is not in agreement with the conclusion of Naga and Geddes (2007) , who reported higher levels of cypD in synaptic mitochondria compared with a nonsynaptic subpopulation. A possible explanation for this discrepancy is that our Western blot protocol includes fixing of the PVDF membrane with glutaraldehyde after transfer of proteins from the SDS gel. This procedure greatly enhances detection of cypD by preventing the loss of the proteins from the membrane during blotting with antibodies and washing procedures (Connern and Halestrap, 1992) . The nonsynaptic fractions used in our immunoblots contain mitochondria primarily from perinuclear regions of neurons and glia that also demonstrate strong immunoreactivity to cypD. The immunoreactivity to cypD of mitochondria located in distal processes and synaptic endings was very weak. Thus, our Western blot results are in agreement with our immunohistochemistry findings. Similarly, the immunoblots confirmed higher levels of cypD in SNr compared with cortex. Striatum showed a tendency toward increased levels of cypD compared with cortex, but the difference was not significant (but see Brustovetsky et al., 2003) . Relative low levels of cypD immunoreactivity in cerebellum, nucleus accumbebs, or corpus callosum can be a consequence of lower cyclophilin mRNA levels in these brain regions (see Lad et al., 1991) .
Our finding that mitochondria preferentially in interneurons contain high levels of cypD has important implications for in vitro studies with isolated brain mitochondria, particularly when the MPT is examined. Brain mitochondria show a very heterogeneous response to MPT-inducing agents. Our data suggest that this heterogeneous response of isolated brain mitochondria to the insult can be due to the different cypD levels in various subpopulations of brain mitochondria. Thus, a subpopulation of isolated mitochondria originating particularly from interneurons will be most sensitive and the rest of the mitochondrial population will be more resistant to calcium-induced MPT. Interneurons represent about 15-30% of all cortical neurons (Parnavelas et al., 1977; Hendry et al., 1987; Meinecke and Peters, 1987) . Because nonsynaptic mitochondria include mitochondria originated from both neurons and glia, the fraction of interneuronal mitochondria is probably less than 15%. Interestingly, this conclusion is in agreement with the finding that only about 10% of isolated nonsynaptic mitochondria display typical signs of swelling (damaged cristae with low electron density and disrupted membranes) when exposed to high levels of calcium (Kristián et al., 2002) . However, other factors can also affect mitochondrial sensitivity to calcium. For example, the endogenous levels of adenine nucleotides modulate the calcium-induced swelling of brain mitochondria (Friberg et al., 1999) . Although our findings show relatively low immunoreactivity of cypD in cerebellum compared with cortex, the higher resistance of cerebellar mitochondria to calcium-induced damage seems to be more a result of higher endogenous adenine nucleotides levels in these mitochondria compared with cortex (Friberg et al., 1999) .
The effect of cypD levels on sensitivity to MPT pore opening were also shown during development (Eliseev et al., 2007) . In newborn rats, sensitivity of brain mitochondria to the MPT and cypD expression is significantly higher than in mature animals. Thus, the lower expression of cypD in adult animals increased the calcium threshold of brain mitochondria to the MPT (Eliseev et al., 2007) . In conclusion, one must exercise caution when studying MPT in isolated brain mitochondria, because only a small population of mitochondria from interneurons will show high sensitivity to calciuminduced damage, whereas the rest of the mitochondrial population will not show typical signs of MPT.
